🇮🇹 Italy Country × Condition
pancreatic cancer Clinical Trials in Italy
Active clinical trials for pancreatic cancer with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇮🇹 Italy
Active Trials in Italy (5)
NCT06069297
Recruiting
Prehabilitation in Pancreatic Surgery
Enrollment
238 pts
Country
🇮🇹 Italy
IRCCS San Raffaele
View Trial → NCT04498767
Recruiting
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Enrollment
200 pts
Country
🇮🇹 Italy
European Organisation for Research ...
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇮🇹 Italy
UMC Utrecht
View Trial → NCT06028724
Recruiting
A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
Enrollment
782 pts
Country
🇮🇹 Italy
Centro di Riferimento Oncologico - ...
View Trial → NCT06777030
Recruiting
Role of Exosomes in Pancreatic Cancer Progression
Enrollment
60 pts
Country
🇮🇹 Italy
IRCCS Azienda Ospedaliero-Universit...
View Trial → Frequently Asked Questions
How many pancreatic cancer clinical trials are active in Italy?
There are currently 5 active clinical trials for pancreatic cancer with sites in Italy, of which 5 are actively recruiting patients.
How can I join a pancreatic cancer clinical trial in Italy?
To join a pancreatic cancer clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are pancreatic cancer trials in Italy?
Active pancreatic cancer trials in Italy span multiple phases. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology